A Practical Roadmap for Piloting and Scaling Bio-Based Solid Waste Management Solutions in Humanitarian Settings

Bio-based products and circular technologies could significantly reduce the environmental footprint of humanitarian operations. Yet, introducing a new material or waste-management solution into a crisis-affected setting is rarely as simple as replacing one product with another.

Will it withstand transport, heat and humidity? Can it be procured under humanitarian rules? Is it affordable? Will communities use it correctly? And, crucially, what will happen to it at the end of its life?

The Bio4HUMAN Replication Roadmap was developed to help humanitarian organisations, authorities, donors, researchers and solution providers answer these questions and move from interest to responsible piloting, replication and possible scale-up.

Replication is more than substitution

The roadmap’s central message is clear: a product is not sustainable simply because it is bio-based, biodegradable or compostable. Its benefits depend on how it performs in real operations and whether the surrounding systems are ready to support it.

A compostable product, for example, may deliver little environmental benefit where waste is mixed, burned or openly dumped. A waste-to-value technology may be technically promising but fail without reliable feedstock, trained operators, maintenance arrangements or a market for its outputs.

The roadmap therefore approaches replication as a sequence of practical decisions: assess local needs, engage stakeholders, evaluate the enabling environment, adapt the solution, conduct a controlled pilot, monitor results and only then consider wider scale-up.

A practical toolkit for piloting and scaling 

Bio4HUMAN does not provide a single blueprint to copy. Instead, it offers adaptable tools that organisations can apply in different countries, programmes and operational settings.

The package includes:

  • A Replication Readiness Checklist covering objectives, current practices, affordability, approvals, delivery models, ethical safeguards, monitoring and long-term ownership;
  • A scenario-based Life Cycle Costing tool for comparing costs, logistics assumptions and affordability;
  • Templates for assessing standards, approvals and supplier evidence;
  • An end-of-life readiness assessment covering segregation, collection, treatment and residual waste;
  • Stakeholder mapping and engagement guidance;
  • Monitoring, evaluation and learning indicators;
  • Solution information sheets and real-world candidate case studies.

Together, these resources help users identify evidence gaps, document assumptions, anticipate barriers and create a transparent case for donors, authorities, clusters and implementing partners.
The roadmap also presents different replication pathways—from relatively straightforward packaging substitutions to integrated systems combining products, waste segregation and local treatment. Candidate cases illustrate institutional biogas installations, service-based enterprises, training hubs and cooperative Black Soldier Fly models that transform organic waste into animal feed and fertiliser. These examples are not intended to be copied exactly, but to show what may become possible when ownership, skills, financing and local market conditions are aligned.

Ten solutions and many possible pathways 

The roadmap builds on ten solutions examined in detail by Bio4HUMAN, including bio-based packaging materials, sanitary pads produced from locally available agricultural materials, biodegradable bags and nets, mycelium-based protective packaging, biogas digesters and Black Soldier Fly treatment.

Some may offer comparatively accessible entry points into greener procurement. Others require new infrastructure, behaviour change, local service models or investment in circular value chains. The solution information sheets provide a practical starting point by summarising functionality, lifespan, cost considerations, environmental value and important operational conditions.

A new field for the bio-based industry

For the bio-based industry, humanitarian aid represents a significant but still underexplored application area.

Humanitarian organisations procure and distribute large volumes of packaging, hygiene items, food-related materials and operational supplies. They also face persistent challenges related to organic waste, plastic pollution, limited treatment infrastructure and costly logistics. These challenges create opportunities for products and systems that are robust, affordable, safe and designed around the realities of humanitarian operations.

However, entry into this market requires more than presenting an environmentally attractive material. Solution providers need to understand humanitarian procurement, international standards, local regulations, climatic conditions, community priorities and the end-of-life systems available in each context. Cost, certification, supply reliability, transparency and evidence of real operational performance remain decisive.

The Bio4HUMAN Replication Roadmap helps bridge this gap. It gives humanitarian actors a structured way to explore innovation, while helping bio-based companies better understand the demand, constraints and partnership models of a potential future market.

The next step is not immediate large-scale replacement. It is careful collaboration: selecting the right solution, adapting it to local realities, testing it responsibly and generating the evidence needed for future adoption.

That is how promising bio-based innovation can become practical, accountable and lasting humanitarian impact.